Webinar: Serum-Free MAb Production Can Cost Less

1 post / 0 new
Brittany
Brittany's picture
Webinar: Serum-Free MAb Production Can Cost Less

 

Serum-Free Cell Culture Can Cost Less: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost

 

 

 
Join us for a Webinar on May 10

 

 

 

 

 

 

Monoclonal antibodies are a valuable asset in the development of future of medicines, from use as basic research tools to large-scale biotherapeutics.  Given the versatility and convenience represented by using hybridomas to produce monoclonal antibodies (MAbs), scientists continue to expand upon the vast potential these proteins represent.  However, limitations in hybridoma productivity and costly purification processes associated with contaminating materials found in the culture medium can significantly increase MAb costs.

In this webinar, we will discuss:
      •  Challenges facing (non-therapeutic) MAb production
      •  Case Study: Lampire Biological Laboratories’ ability to positively impact
         cost and performance under serum-free conditions
      •  Elimination of animal-derived components to improve
                 - purification processes,
                 - consistency of system performance, and
                 - regulatory compliance

Join us today for a live one hour event!

Title:
Serum-Free Cell Culture Can Cost Less: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost

Date:
Tuesday, May 10, 2011

Time:
11:30 AM - 12:30 PM MDT

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server

 

Macintosh®-based attendees
Required: Mac OS® X 10.4.11 (Tiger®) or newer

 

Space is limited.
Reserve your Webinar seat now at:
https://www3.gotomeeting.com/register/126507854